2275 - Repurposing FDA-Approved Drugs and Host Cell Membranes to Treat Toxin-Driven Bacterial Infection and Sepsis

Saturday, October 22, 2022

2:35 PM – 3:00 PM US ET

Location: 143 ABC

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Speaker(s)

Victor Nizet, MD (he/him/his)

Distinguished Professor and Vice Chair
University of California San Diego
San Diego, CA, United States

Disclosure: Disclosure(s): Cellics Therapeutics: Advisor/Consultant (Ongoing); Clarametyx Biosciences: Advisor/Consultant (Ongoing); Vaxcyte, Inc.: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing)

Disclosure(s):

Victor Nizet, MD: Cellics Therapeutics: Advisor/Consultant (Ongoing); Clarametyx Biosciences: Advisor/Consultant (Ongoing); Vaxcyte, Inc.: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing)